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Introduction / objectives
Infection with carbapenem resistant A. baumannii (CR-
AB)and P. aeruginosa (CR-PS) as well as ESBL-produ-
cing organisms have caused high rate of mortality. This
project was aimed to survey the prevalence of drug
resistant organisms colonization in critical care patients
as a part of infection control program.
Methods
Perianal swab, urine (from Foley’s catheter) and endo-
tracheal catheter (ET) were collected from patients who
were admitted to intensive care units of a 1000-bed hos-
pital. Isolation of CR-AB and CR-PS was using EMB
agar containing 12 ug/ml of either imipenem or mero-
penem. The MacConkey agar containing 1 ug/ml of
cefotaxime was used for screening of ESBL-producing
organisms. The MIC of these organisms was performed
using THANF customised panel (Sensititre, UK).
Results
A total of 81 isolates was detected from 39 patients.
There were 53, 22 and 6 isolates of ESBL-producing
organisms, CR-AB and CR-PS, respectively. Perianal was
found to be the most common site for colonisation with
ESBL-producing organisms (45/60 isolates) while 8 of
14 isolates from ET were CR-AB. All CR-AB isolates
resisted to nearly all tested antibiotics. However, all iso-
lates were susceptible to colistin and tigecycline with the
MIC90 at ≤1 and 1 ug/ml, respectively. In contrast, the
ESBL-producing organisms remained susceptible to all
tested carbapenems. Nevertheless, 68% of these isolates
resisted to fluoroquinolones.
Conclusion
This project is a part of implementation of hospital-
acquired infection control policy. The data demon-
strated the existing of various multiple-drugs resistant
organisms in critical care patients which would be a
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